Lundbeck
HLUN-B.CO
#2796
Rank
โ‚น616.62 B
Marketcap
โ‚น621.51
Share price
-2.06%
Change (1 day)
16.69%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Earnings for Lundbeck (HLUN-B.CO)

Earnings in 2026 (TTM): โ‚น76.69 Billion

According to Lundbeck's latest financial reports the company's current earnings are โ‚น4.00 Billion. In 2025 the company made an earning of โ‚น72.59 Billion, an increase over its 2024 earnings that were of โ‚น52.82 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lundbeck from 2009 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น76.69 B5.63%
2025 โ‚น72.59 B37.43%
2024 โ‚น52.82 B25.74%
2023 โ‚น42.01 B21.77%
2022 โ‚น34.50 B31.57%
2021 โ‚น26.22 B-4.61%
2020 โ‚น27.49 B-45.06%
2019 โ‚น50.04 B-34.04%
2018 โ‚น75.87 B12.83%
2017 โ‚น67.24 B93.99%
2016 โ‚น34.66 B-137.28%
2015 -โ‚น92.98 Billion-1246.24%
2014 โ‚น8.11 B-72.36%
2013 โ‚น29.34 B4.38%
2012 โ‚น28.11 B-55.18%
2011 โ‚น62.73 B5.65%
2010 โ‚น59.37 B-5.9%
2009 โ‚น63.10 B